260 related articles for article (PubMed ID: 36376825)
1. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck.
Norouzian M; Mehdipour F; Ashraf MJ; Khademi B; Ghaderi A
BMC Immunol; 2022 Nov; 23(1):56. PubMed ID: 36376825
[TBL] [Abstract][Full Text] [Related]
2. Determination of a CD4
Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
Drennan S; Stafford ND; Greenman J; Green VL
Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
[TBL] [Abstract][Full Text] [Related]
4. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
5. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
6. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.
Mehdipour F; Razmkhah M; Faghih Z; Bagheri M; Talei AR; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):381-395. PubMed ID: 30850950
[TBL] [Abstract][Full Text] [Related]
7. Significance of TIM-3 expression by CD4
Shariati S; Ghods A; Zohouri M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2020 Dec; 128():47-54. PubMed ID: 33068833
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
9. GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes.
Krausz LT; Fischer-Fodor E; Major ZZ; Fetica B
Int J Immunopathol Pharmacol; 2012; 25(1):59-66. PubMed ID: 22507318
[TBL] [Abstract][Full Text] [Related]
10. CD45RA
Ihara F; Sakurai D; Horinaka A; Makita Y; Fujikawa A; Sakurai T; Yamasaki K; Kunii N; Motohashi S; Nakayama T; Okamoto Y
Cancer Immunol Immunother; 2017 Oct; 66(10):1275-1285. PubMed ID: 28551813
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
[TBL] [Abstract][Full Text] [Related]
12. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.
Sun W; Li WJ; Wu CY; Zhong H; Wen WP
J Exp Clin Cancer Res; 2014 Apr; 33(1):35. PubMed ID: 24761979
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
[TBL] [Abstract][Full Text] [Related]
14. Expression of regulatory T cells in jejunum, colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania infantum.
Figueiredo MM; Deoti B; Amorim IF; Pinto AJ; Moraes A; Carvalho CS; da Silva SM; de Assis AC; de Faria AM; Tafuri WL
Infect Immun; 2014 Sep; 82(9):3704-12. PubMed ID: 24935975
[TBL] [Abstract][Full Text] [Related]
15. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
[TBL] [Abstract][Full Text] [Related]
16. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
18. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
19. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
20. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]